KraneShares MSCI Emerging Markets ex China Index ETF (KEMX)
Live price chart, market sentiment, and community perspectives for KraneShares MSCI Emerging Markets ex China Index ETF (AMEX: KEMX).
Live price chart, market sentiment, and community perspectives for KraneShares MSCI Emerging Markets ex China Index ETF (AMEX: KEMX).
Evaluating liquidity and execution costs, KEMX has matured significantly. Authorized participants are efficiently managing the creation and redemption baskets despite the disparate custody requirements across multiple Asian jurisdictions, keeping secondary market spreads tight enough for institutional tactical rebalancing.
From a fundamental equity research standpoint, the exclusion of state-owned Chinese enterprises fundamentally alters the quality of earnings within the KEMX portfolio. You are trading state-directed capital allocation for market-driven, export-oriented profitability, resulting in a cleaner return on equity profile across the top holdings.
Looking at KEMX through a macro lens, the structural thesis rests entirely on the ongoing supply chain relocation out of mainland China. India, Vietnam, and Indonesia are capturing massive foreign direct investment, and KEMX provides a liquid, tradeable proxy to monetize this multi-decade manufacturing migration without getting bogged down in illiquid local frontier market exchanges.
As a risk manager overseeing cross-border allocations, my primary concern with KEMX isn't domestic economic failure, but rather geopolitical tail risk in the South China Sea. While the fund successfully removes domestic Chinese corporate governance risks, its heavy reliance on Taiwanese semiconductor fabrication introduces a single-point-of-failure concentration risk that demands active tail-hedging.
From a quantitative portfolio construction perspective, KEMX solves the persistent problem of China's overwhelming gravity in standard emerging market benchmarks. When running risk models, separating the high-beta technology exposure of Taiwan and Korea from mainland regulatory friction drastically improves our Sharpe ratio optimization and lowers tracking error against developed market benchmarks.
Explore plasma cleansing, somatic organ swaps, and BCI.